The Government's difficult fiscal circumstances suggest that stakeholders should exercise caution in framing their responses to tonight's 2023-24 Budget simply because they cannot know what 'decisions taken but not yet announced' are hidden in the contingency reserve. …
Cautious response required given the sector's experience with the 'contingency reserve'
May 9, 2023 Latest NewsBioPharma
Latest Video
Georgia Forrest
New Stories
-
GBMA moves to reclaim the reform agenda with a focus on pricing and supply
February 5, 2026 - - Latest News -
Nuclear medicine sector argues for dedicated scheme to unlock cancer therapies
February 4, 2026 - - Latest News -
Pfizer’s once-monthly weight-loss injection delivers strong mid-stage results
February 4, 2026 - - Latest News -
GBMA Summit focuses on access, affordability and security in an uncertain world
February 4, 2026 - - Latest News -
Medicines Australia calls for Budget action to restore access to innovative medicines
February 3, 2026 - - Latest News -
Survey exposes deep gaps in support for Australians living with rare cancers
February 3, 2026 - - Latest News -
Juvenile Arthritis Foundation Australia seeks new CEO as Angela McKay steps down
February 3, 2026 - - Latest News